Category: law

Opinion: A sloppy report on mifepristone is being used to undermine the FDA — and the biotech industry For decades, the Food and Drug Administration has partnered with clinicians and industry to deliver evidence-based medical innovations using a gold-standard framework for drug development and oversight. The agency has the authority to review any approved drug,…